ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Anticipated Cost Savings of Using Lungs from Hepatitis C-Positive Lung Donors for Hepatitis C-Negative Recipients

    K. Ryland1, J. Mallea2, J. Moriarty3, L. White4, B. Borah5, J. Naessens3

    1Transplantation, Mayo Clinic, Jacksonville, FL, 2Medicine, Mayo Clinic, Jacksonville, FL, 3Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Jacksonville, FL, 5Health Sciences Research, Mayo Clinic, Rochester, MN

    *Purpose: We assessed the cost savings generated by additional organ availability due to utilizing lungs from hepatitis-C infected donors for transplantation in comparison to existing…
  • 2020 American Transplant Congress

    TIM-4+ Kupffer Cells Play Homeostatic Roles in Liver Ischemia Reperfusion Injury

    M. Ni1, J. Zhang1, R. Sosa2, S. Kageyama1, R. Busuttil1, R. Elaine2, J. Kupiec-Weglinski1, X. Wang3, Y. Zhai1

    1Dumont-UCLA Transplant Center, Los Angeles, CA, 2Pathology, David Geffen School of Medicine-UCLA, Los Angeles, CA, 3Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

    *Purpose: Liver ischemia reperfusion injury (IRI) remains a significant clinical problem. Although the molecular mechanism of liver inflammatory response against IR has been studied extensively,…
  • 2020 American Transplant Congress

    T Cell Activation by Allogeneic EVs and Allogeneic MHC Cross-Dressed Cells In Vitro and In Vivo

    A. Prunevieille1, B. Gonzalez-Nolasco1, G. Benichou1, N. Mooney2, A. Colleen3

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2INSERM, Paris, France, 3Boston College, Boston, MA

    *Purpose: The recognition of donor-MHC molecules by recipient T cells triggers the immune response leading to rejection of allografts. Our recent studies have documented the…
  • 2020 American Transplant Congress

    Consequences of Turning Down High KDPI Kidney Organ Offers for Kidney Transplant Candidates

    J. D. Motter, L. Liyanage, K. R. Jackson, M. G. Bowring, T. Ishaque, Y. Yu, S. Yu, J. M. Garonzik-Wang, A. B. Massie, D. L. Segev

    Johns Hopkins University, Baltimore, MD

    *Purpose: Kidneys with a high Kidney Donor Profile Index (KDPI, 80-100%) are frequently declined as they are associated with higher graft loss; yet, candidates that…
  • 2020 American Transplant Congress

    Change In i-IFTA Associated with Treatment of Rejection

    N. Garg, B. C. Astor, S. Parajuli, F. Aziz, M. Mohamed, W. Zhong, A. Djamali, D. A. Mandelbrot

    UW-Madison, Madison, WI

    *Purpose: Recent studies have shown that inflammation in areas of interstitial fibrosis and tubular atrophy (i-IFTA) is associated with worse kidney allograft outcomes. How i-IFTA…
  • 2020 American Transplant Congress

    Hepatic Artery Reconstruction in Living Donor Liver Transplantation Using Surgical Loupes: Achieving Low Rate of Hepatic Arterial Thrombosis in Consecutive 1000 Recipients- Tips and Tricks to Overcome the Poor Hepatic Arterial Flow

    A. Thorat, L. Jeng, S. Hsu, P. Li, H. Yang, T. Chen, K. Poon

    Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan

    *Purpose: The reconstruction of hepatic artery (HA) is most complex step in living donor liver transplantation (LDLT) due to smaller diameter of the artery and…
  • 2020 American Transplant Congress

    Process Matters: Factors in Refusing Solid Organ Donation by African Americans

    L. A. Siminoff1, G. P. Alolod1, H. M. Gardiner1, R. D. Hasz2, P. A. Mulvania2, M. Wilson-Genderson1

    1Social and Behavioral Sciences, Temple University, Philadelphia, PA, 2Gift of Life Donor Program, Philadelphia, PA

    *Purpose: With approximately 25 African Americans (AAs) dying weekly while awaiting a transplantable organ, this study compares the experiences of AA families who authorized donation…
  • 2020 American Transplant Congress

    Recruitment of Regulatory T Cells Promotes Donor-Specific Tolerance in Vascularized Composite Allotransplantation

    J. D. Fisher1, W. Zhang2, S. C. Balmert3, A. M. Aral1, Y. Kulahci4, A. P. Acharya4, J. Li2, H. R. Turnquist5, A. W. Thomson5, M. G. Solari2, V. S. Gorantla6, S. R. Little4

    1Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, 2Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, PA, 3Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, 4Department of Chemical Engineering, University of Pittsburgh, Pittsburgh, PA, 5Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, 6Department of Bioengineering, Wake Forest University, Winston-Salem, NC

    *Purpose: Vascularized composite allotransplantation (VCA) encompasses face and limb transplantation, but as with organ transplantation, it requires lifelong regimens of immunosuppressive drugs to prevent rejection.*Methods:…
  • 2020 American Transplant Congress

    New Strategy to Maximize Nanomedicine Delivery During Ex Vivo Organ Perfusion

    C. Albert1, L. Bracaglia1, A. Koide2, C. M. Edwards3, T. Lysyy3, J. S. Pober4, M. Saltzman1, S. Koide2, G. Tietjen3

    1Biomedical Engineering, Yale University, New Haven, CT, 2Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, 3Surgery, Yale University, New Haven, CT, 4Immunobiology, Yale University, New Haven, CT

    *Purpose: Organ transplant is a highly successful therapy for patients facing end stage organ failure. However, there is a severe lack of transplantable organs which…
  • 2020 American Transplant Congress

    Oxidative Stress Induces Cytoprotective Alternative Splicing in Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 in Mouse Liver Ischemia-Reperfusion Injury

    K. J. Dery, H. Hirao, K. Kadono, S. Kageyama, H. Kojima, R. W. Busuttil, J. W. Kupiec-Weglinski

    Surgery, Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA

    *Purpose: We have recently shown that carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) serves as a checkpoint regulator in liver transplant (LT) ischemia-reperfusion injury (IRI);…
  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences